ARMP
Armata Pharmaceuticals Inc
Halal Rating :
Last Price
$2.08
Last updated:
Market Cap
-
7D Change
2.97%
1 Year Change
-46.39%
Company Overview
Industries
Exchange
Next Earnings Date
Armata Pharmaceuticals Inc is a biotechnology company focused on developing bacteriophage-based therapies for the treatment of drug-resistant bacterial infections. The company's main product candidates include AP-PA02 for Pseudomonas aeruginosa infections and AP-SA02 for Staphylococcus aureus infections. The company is primarily in the research and development phase.
Use of Interest
| Reporting Date | Total Revenue | Total Operating Expense | Interest Income | Interest Expense | Interest Income Ratio | Interest Expense Ratio |
|---|---|---|---|---|---|---|
| Sept. 30, 2024 | $2.97m | $12.73m | - | - | 0.00% | 0.00% |
| March 31, 2024 | $966000.0 | $13.01m | - | $1.82m | 0.00% | 13.98% |
Company Impact
Help us evaluate Armata Pharmaceuticals Inc's impact from a halal perspective. Vote on the most significant aspect and submit any considerations that we may have missed.